Thus, the main aim of this study was to evaluate how the modification of radiometal-chelate complex would influence the biodistribution and tumor-targeting properties of Ec1 labelled with gallium-68 for visualizing the EpCAM expression. The gene discussed is EPCAM; the disease is neoplasm.